CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 450 enrolled
Drug / intervention
Peripherally Inserted Central Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04263649
NCT04263649N/ACompleted

Prospective Observational Study of the Power PICC Family of Devices and Accessories

Becton, Dickinson and Company·observational·Posted Feb 11, 2020·Updated Aug 19, 2024

In Brief

An observational study evaluating Peripherally Inserted Central Catheter for Peripherally Inserted Central Catheter. Completed, enrolled 450 participants across 14 sites in 9 countries.

Detailed Summary

Post-market, observational study to collect prospective data related to the safety and performance of the Power PICC family of devices and its accessories in a real-world setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, Czechia, Denmark, Germany, Italy, Netherlands, Spain, Switzerland

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 11, 2020
Enrollment StartJun 18, 2020
Primary CompletionJan 5, 2022
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 6.4 years ago

Interventions

Peripherally Inserted Central Catheterdevice

insertion of a Peripherally Inserted Central Catheter (PICC)